フィナフロキサシン
|
|
|
- CAS番号.
- 209342-40-5
- 化学名:
- フィナフロキサシン
- 别名:
- フィナフロキサシン
- 英語名:
- 3-Quinolinecarboxylic acid, 8-cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b]-1,4-oxazin-6(2H)-yl]-1,4-dihydro-4-oxo-
- 英語别名:
- 100827;Finafloxacin;Finafloxacin Otic;Valine Impurity 71;Finafloxacin (Xtoro);Finafloxacin >=95% (HPLC);Finafloxacin (BAY35-3377);BAY35-3377,finafloxacin hydrochloride;8-Cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b][1,4]oxazin-6(2H)-yl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid;8-cyano-1-cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydropyrrolo[3,4-b][1,4]oxazin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- CBNumber:
- CB42605885
- 化学式:
- C20H19FN4O4
- 分子量:
- 398.39
- MOL File:
- 209342-40-5.mol
- MSDS File:
- SDS
|
フィナフロキサシン 物理性質
- 沸点 :
- 686.2±55.0 °C(Predicted)
- 比重(密度) :
- 1.57±0.1 g/cm3(Predicted)
- 貯蔵温度 :
- -20°C
- 溶解性:
- DMSO : 6.4 mg/mL (16.06 mM)
- 酸解離定数(Pka):
- 6.38±0.50(Predicted)
- 外見 :
- 粉
- 色:
- 白からベージュ
安全性情報
- リスクと安全性に関する声明
- 危険有害性情報のコード(GHS)
| 絵表示（GHS） |
|
| 注意喚起語 |
危険 |
| 危険有害性情報 |
| コード |
危険有害性情報 |
危険有害性クラス |
区分 |
注意喚起語 |
シンボル |
P コード |
| H340 |
遺伝性疾患のおそれ |
生殖細胞変異原性 |
1A, 1B |
危険 |
|
|
|
| 注意書き |
| P201 |
使用前に取扱説明書を入手すること。 |
| P308+P313 |
暴露または暴露の懸念がある場合：医師の診断/手当てを 受けること。 |
|
フィナフロキサシン 価格
もっと(2)
| メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
|
Sigma-Aldrich Japan
|
SML2134 |
≥95% (HPLC)
Finafloxacin ≥95% (HPLC) |
209342-40-5 |
10mg |
￥12900 |
2024-03-01 |
購入 |
|
Sigma-Aldrich Japan
|
SML2134 |
≥95% (HPLC)
Finafloxacin ≥95% (HPLC) |
209342-40-5 |
50mg |
￥50800 |
2024-03-01 |
購入 |
フィナフロキサシン 化学特性,用途語,生産方法
効能
抗菌薬, 核酸合成阻害薬
説明
Finafloxacin, an antimicrobial agent of the 8-cyano subclass of
fluoroquinolones, was approved by the US FDA in December
2014 for treatment of acute otitis externa, commonly known as
swimmer’s ear, caused by susceptible strains of Pseudomonas
aeruginosa and Staphylococcus aureus. Finafloxacin was
developed by MerLion Pharmaceuticals in partnership with Bayer
Health Care Pharmaceuticals, and the drug was licensed by Mer-
Lion to Alcon (a division of Novartis) for development and commercialization
for ear infections in North America. In
contrast to other marketed fluoroquinolones, which display
reduced activity in slightly acidic environments, finafloxacin exhibits
increased antibacterial activity at pH 5–6, with minimum inhibitory
concentration values that are 4- to 8-fold lower than at
neutral pH. It is highly selective for bacterial type II topoisomerases,
which are involved in bacterial DNA replication, transcription,
repair, and recombination, and has broad spectrum
antibacterial activity against Gram-positive and Gram-negative
strains, including ciprofloxacin-resistant strains.
使用
Used for the preparation of naphthyridonecarboxylic acid derivatives as drugs for therapy of Helicobacter pylori infections and associated gastroduodenal illnesses.
定義
ChEBI: A quinolone that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted at positions 1, 6, 7 and 8 by cyclopropyl, fluoro, hexahydropyrrolo[3,4-b][1,4]oxazin-6-yl and cyano groups respectively; an antibiotic used for treatment of
acute otitis externa (swimmer's ear) caused by the bacteria Pseudomonas aeruginosa and Staphylococcus aureus.
フィナフロキサシン 上流と下流の製品情報
原材料
準備製品
フィナフロキサシン 生産企業
Global( 50)Suppliers
209342-40-5(フィナフロキサシン)キーワード:
- 209342-40-5
- 3-Quinolinecarboxylic acid, 8-cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b]-1,4-oxazin-6(2H)-yl]-1,4-dihydro-4-oxo-
- Finafloxacin
- BAY35-3377,finafloxacin hydrochloride
- 8-cyano-1-cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydropyrrolo[3,4-b][1,4]oxazin-6(2H)-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
- 8-Cyano-1-cyclopropyl-6-fluoro-7-[(4aS,7aS)-hexahydropyrrolo[3,4-b][1,4]oxazin-6(2H)-yl]-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
- Finafloxacin (BAY35-3377)
- 100827
- (-)-(4aS,7aS)-8-Cyano-1-cyclopropyl-6-fluoro-4-oxo-7-(perhydropyrrolo[3,4-b]-1,4-oxazin-6-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
- Finafloxacin >=95% (HPLC)
- Finafloxacin (Xtoro)
- Finafloxacin Otic
- (-)-(4aS,7aS)-8-Cyano-1-cyclopropyl-6-fluoro-4-oxo-7-(perhydropyrrolo[3,4-b]-1,4-oxazin-6-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
- Valine Impurity 71
- フィナフロキサシン